SELP and COVID-19: The finding foresees the future application of P-selectin as an early diagnostic marker for risk stratification, monitoring of disease progression, and facilitating personalized medicine not only in COVID-19 patients but also in other diseases in which endothelial dysfunction plays a critical role.